Inter-subject variability in Full replicate design [RSABE / ABEL]
Dear All,
Need help on formula/procedure to find out the Intersubject Variability for a Full replicate design using SAS.
Based on the Program given in the progesterone guideline below:
As there is no subj(seq) in the random statement, I am not able to calculate the inter-subject variabilities for test and reference treatments. Please help me with this calculation.
But when I use the proc varcomp procedure in SAS, I am able to generate the Variabilities (Inter and Intra) for test and reference treatments. My doubt is that whether it is acceptable by FDA regulatory?
Thanks in Advance,
Need help on formula/procedure to find out the Intersubject Variability for a Full replicate design using SAS.
Based on the Program given in the progesterone guideline below:
PROC MIXED
data=pk;
CLASSES SEQ SUBJ PER TRT;
MODEL LAUCT = SEQ PER TRT/ DDFM=SATTERTH;
RANDOM TRT/TYPE=FA0(2) SUB=SUBJ G;
REPEATED/GRP=TRT SUB=SUBJ;
ESTIMATE 'T vs. R' TRT 1 -1/CL ALPHA=0.1;
ods output Estimates=unsc1;
title1 'unscaled BE 90% CI - guidance version';
title2 'AUCt';
As there is no subj(seq) in the random statement, I am not able to calculate the inter-subject variabilities for test and reference treatments. Please help me with this calculation.
But when I use the proc varcomp procedure in SAS, I am able to generate the Variabilities (Inter and Intra) for test and reference treatments. My doubt is that whether it is acceptable by FDA regulatory?
Thanks in Advance,
—
Regards,
MGR
Regards,
MGR
Complete thread:
- Inter-subject variability in Full replicate designMGR 2021-09-30 07:35 [RSABE / ABEL]
- Inter-subject variability in Full replicate design ElMaestro 2021-09-30 14:04
- Inter-subject variability in Full replicate design Helmut 2021-09-30 15:25